Literature DB >> 19423537

Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium.

Mia M Gaudet1, Roger L Milne, Angela Cox, Nicola J Camp, Ellen L Goode, Manjeet K Humphreys, Alison M Dunning, Jonathan Morrison, Graham G Giles, Gianluca Severi, Laura Baglietto, Dallas R English, Fergus J Couch, Janet E Olson, Xianshu Wang, Jenny Chang-Claude, Dieter Flesch-Janys, Sascha Abbas, Ramona Salazar, Arto Mannermaa, Vesa Kataja, Veli-Matti Kosma, Annika Lindblom, Sara Margolin, Tuomas Heikkinen, Kati Kämpjärvi, Kirsimari Aaltonen, Heli Nevanlinna, Natalia Bogdanova, Irina Coinac, Peter Schürmann, Thilo Dörk, Claus R Bartram, Rita K Schmutzler, Sandrine Tchatchou, Barbara Burwinkel, Hiltrud Brauch, Diana Torres, Ute Hamann, Christina Justenhoven, Gloria Ribas, José I Arias, Javier Benitez, Stig E Bojesen, Børge G Nordestgaard, Henrik L Flyger, Julian Peto, Olivia Fletcher, Nichola Johnson, Isabel Dos Santos Silva, Peter A Fasching, Matthias W Beckmann, Reiner Strick, Arif B Ekici, Annegien Broeks, Marjanka K Schmidt, Flora E van Leeuwen, Laura J Van't Veer, Melissa C Southey, John L Hopper, Carmel Apicella, Christopher A Haiman, Brian E Henderson, Loic Le Marchand, Laurence N Kolonel, Vessela Kristensen, Grethe Grenaker Alnaes, David J Hunter, Peter Kraft, David G Cox, Susan E Hankinson, Caroline Seynaeve, Maaike P G Vreeswijk, Rob A E M Tollenaar, Peter Devilee, Stephen Chanock, Jolanta Lissowska, Louise Brinton, Beata Peplonska, Kamila Czene, Per Hall, Yuqing Li, Jianjun Liu, Sabapathy Balasubramanian, Saeed Rafii, Malcolm W R Reed, Karen A Pooley, Don Conroy, Caroline Baynes, Daehee Kang, Keun-Young Yoo, Dong-Young Noh, Sei-Hyun Ahn, Chen-Yang Shen, Hui-Chun Wang, Jyh-Cherng Yu, Pei-Ei Wu, Hoda Anton-Culver, Argyrios Ziogoas, Kathleen Egan, Polly Newcomb, Linda Titus-Ernstoff, Amy Trentham Dietz, Alice J Sigurdson, Bruce H Alexander, Parveen Bhatti, Kristina Allen-Brady, Lisa A Cannon-Albright, Jathine Wong, Georgia Chenevix-Trench, Amanda B Spurdle, Jonathan Beesley, Paul D P Pharoah, Doug F Easton, Montserrat Garcia-Closas.   

Abstract

Previous studies have suggested that minor alleles for ERCC4 rs744154, TNF rs361525, CASP10 rs13010627, PGR rs1042838, and BID rs8190315 may influence breast cancer risk, but the evidence is inconclusive due to their small sample size. These polymorphisms were genotyped in more than 30,000 breast cancer cases and 30,000 controls, primarily of European descent, from 30 studies in the Breast Cancer Association Consortium. We calculated odds ratios (OR) and 95% confidence intervals (95% CI) as a measure of association. We found that the minor alleles for these polymorphisms were not related to invasive breast cancer risk overall in women of European descent: ECCR4 per-allele OR (95% CI) = 0.99 (0.97-1.02), minor allele frequency = 27.5%; TNF 1.00 (0.95-1.06), 5.0%; CASP10 1.02 (0.98-1.07), 6.5%; PGR 1.02 (0.99-1.06), 15.3%; and BID 0.98 (0.86-1.12), 1.7%. However, we observed significant between-study heterogeneity for associations with risk for single-nucleotide polymorphisms (SNP) in CASP10, PGR, and BID. Estimates were imprecise for women of Asian and African descent due to small numbers and lower minor allele frequencies (with the exception of BID SNP). The ORs for each copy of the minor allele were not significantly different by estrogen or progesterone receptor status, nor were any significant interactions found between the polymorphisms and age or family history of breast cancer. In conclusion, our data provide persuasive evidence against an overall association between invasive breast cancer risk and ERCC4 rs744154, TNF rs361525, CASP10 rs13010627, PGR rs1042838, and BID rs8190315 genotypes among women of European descent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19423537      PMCID: PMC2737177          DOI: 10.1158/1055-9965.EPI-08-0745

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  19 in total

1.  Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.

Authors:  S L Starcevic; C Elferink; R F Novak
Journal:  J Natl Cancer Inst       Date:  2001-05-16       Impact factor: 13.506

2.  Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer.

Authors:  Sang-Ah Lee; Kyoung-Mu Lee; Woong-Yang Park; Bongcheol Kim; Jinwu Nam; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; Ari Hirvonen; Daehee Kang
Journal:  Exp Mol Med       Date:  2005-04-30       Impact factor: 8.718

3.  Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant.

Authors:  Bernd Frank; Kari Hemminki; Barbara Wappenschmidt; Alfons Meindl; Rüdiger Klaes; Rita K Schmutzler; Peter Bugert; Michael Untch; Claus R Bartram; Barbara Burwinkel
Journal:  Carcinogenesis       Date:  2005-10-26       Impact factor: 4.944

4.  Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.

Authors:  Dora Il'yasova; Lisa H Colbert; Tamara B Harris; Anne B Newman; Douglas C Bauer; Suzanne Satterfield; Stephen B Kritchevsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

5.  Caspase-10 sensitizes breast carcinoma cells to TRAIL-induced but not tumor necrosis factor-induced apoptosis in a caspase-3-dependent manner.

Authors:  Ingo H Engels; Gudrun Totzke; Ute Fischer; Klaus Schulze-Osthoff; Reiner U Jänicke
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

6.  Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk.

Authors:  David A Ralph; Lue Ping Zhao; Christopher E Aston; Sharmila Manjeshwar; Thomas W Pugh; Daniele C DeFreese; Bobby A Gramling; Craig D Shimasaki; Eldon R Jupe
Journal:  Cancer       Date:  2007-05-15       Impact factor: 6.860

7.  A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.

Authors:  Immaculata De Vivo; Susan E Hankinson; Graham A Colditz; David J Hunter
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

8.  Association of a common variant of the CASP8 gene with reduced risk of breast cancer.

Authors:  Gordon MacPherson; Catherine S Healey; M Dawn Teare; Sabapathy P Balasubramanian; Malcolm W R Reed; Paul D P Pharoah; Bruce A J Ponder; Mark Meuth; Nitai P Bhattacharyya; Angela Cox
Journal:  J Natl Cancer Inst       Date:  2004-12-15       Impact factor: 13.506

9.  A common coding variant in CASP8 is associated with breast cancer risk.

Authors:  Angela Cox; Alison M Dunning; Montserrat Garcia-Closas; Sabapathy Balasubramanian; Malcolm W R Reed; Karen A Pooley; Serena Scollen; Caroline Baynes; Bruce A J Ponder; Stephen Chanock; Jolanta Lissowska; Louise Brinton; Beata Peplonska; Melissa C Southey; John L Hopper; Margaret R E McCredie; Graham G Giles; Olivia Fletcher; Nichola Johnson; Isabel dos Santos Silva; Lorna Gibson; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Diana Torres; Ute Hamann; Christina Justenhoven; Hiltrud Brauch; Jenny Chang-Claude; Silke Kropp; Angela Risch; Shan Wang-Gohrke; Peter Schürmann; Natalia Bogdanova; Thilo Dörk; Rainer Fagerholm; Kirsimari Aaltonen; Carl Blomqvist; Heli Nevanlinna; Sheila Seal; Anthony Renwick; Michael R Stratton; Nazneen Rahman; Suleeporn Sangrajrang; David Hughes; Fabrice Odefrey; Paul Brennan; Amanda B Spurdle; Georgia Chenevix-Trench; Jonathan Beesley; Arto Mannermaa; Jaana Hartikainen; Vesa Kataja; Veli-Matti Kosma; Fergus J Couch; Janet E Olson; Ellen L Goode; Annegien Broeks; Marjanka K Schmidt; Frans B L Hogervorst; Laura J Van't Veer; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; Sara Wedrén; Per Hall; Yen-Ling Low; Jianjun Liu; Roger L Milne; Gloria Ribas; Anna Gonzalez-Neira; Javier Benitez; Alice J Sigurdson; Denise L Stredrick; Bruce H Alexander; Jeffery P Struewing; Paul D P Pharoah; Douglas F Easton
Journal:  Nat Genet       Date:  2007-02-11       Impact factor: 38.330

10.  PedGenie: meta genetic association testing in mixed family and case-control designs.

Authors:  Karen Curtin; Jathine Wong; Kristina Allen-Brady; Nicola J Camp
Journal:  BMC Bioinformatics       Date:  2007-11-15       Impact factor: 3.169

View more
  30 in total

1.  Association of five single nucleotide polymorphisms at 6q25.1 with breast cancer risk in northwestern China.

Authors:  Long Zhou; Na He; Tian Feng; Tingting Geng; Tianbo Jin; Chao Chen
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

2.  Association between BH3 interacting domain death agonist (BID) gene polymorphism and ossification of the posterior longitudinal ligament in Korean population.

Authors:  Jinmann Chon; Jang-Hyeok Hong; Jinsung Kim; Yoo Jin Han; Byoung Wook Lee; Soo-Cheol Kim; Dong Hwan Kim; Seung Don Yoo; Hee-Sang Kim; Dong Hwan Yun
Journal:  Mol Biol Rep       Date:  2014-01-08       Impact factor: 2.316

3.  Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.

Authors:  Rabeb M Ghali; Maryam A Al-Mutawa; Bashayer H Ebrahim; Hanen H Jrah; Sonia Zaied; Hanen Bhiri; Fahmi Hmila; Touhami Mahjoub; Wassim Y Almawi
Journal:  Pathol Oncol Res       Date:  2018-01-04       Impact factor: 3.201

4.  Polymorphisms in ESR1 and FLJ43663 are associated with breast cancer risk in the Han population.

Authors:  Peng Xia; Tianbo Jin; Tingting Geng; Ting Sun; Xiaolan Li; Chengxue Dang; Longli Kang; Chao Chen; Jiying Sun
Journal:  Tumour Biol       Date:  2013-10-15

5.  Association between the TNF-α-238G>A and TGF-β1 L10P Polymorphisms and Breast Cancer Risk: A Meta-Analysis.

Authors:  Jun Guo; Hua Meng; Jianming Pei; Miaozhang Zhu
Journal:  Breast Care (Basel)       Date:  2011-04-29       Impact factor: 2.860

6.  Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.

Authors:  Eunjung Lee; Sue A Ingles; David Van Den Berg; Wei Wang; Chris Lavallee; Mei-Hua Huang; Carolyn J Crandall; Frank Z Stanczyk; Gail A Greendale; Giske Ursin
Journal:  Menopause       Date:  2012-03       Impact factor: 2.953

7.  Single nucleotide variants in metastasis-related genes are associated with breast cancer risk, by lymph node involvement and estrogen receptor status, in women with European and African ancestry.

Authors:  Michelle R Roberts; Lara E Sucheston-Campbell; Gary R Zirpoli; Michael Higgins; Jo L Freudenheim; Elisa V Bandera; Christine B Ambrosone; Song Yao
Journal:  Mol Carcinog       Date:  2016-09-21       Impact factor: 4.784

Review 8.  Rat models of 17β-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention.

Authors:  James D Shull; Kirsten L Dennison; Aaron C Chack; Amy Trentham-Dietz
Journal:  Physiol Genomics       Date:  2018-01-26       Impact factor: 3.107

9.  Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women.

Authors:  Courtney A Gabriel; Nandita Mitra; Angela Demichele; Timothy Rebbeck
Journal:  Breast Cancer Res Treat       Date:  2013-06-14       Impact factor: 4.872

10.  Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).

Authors:  A Osorio; R L Milne; G Pita; P Peterlongo; T Heikkinen; J Simard; G Chenevix-Trench; A B Spurdle; J Beesley; X Chen; S Healey; S L Neuhausen; Y C Ding; F J Couch; X Wang; N Lindor; S Manoukian; M Barile; A Viel; L Tizzoni; C I Szabo; L Foretova; M Zikan; K Claes; M H Greene; P Mai; G Rennert; F Lejbkowicz; O Barnett-Griness; I L Andrulis; H Ozcelik; N Weerasooriya; A-M Gerdes; M Thomassen; D G Cruger; M A Caligo; E Friedman; B Kaufman; Y Laitman; S Cohen; T Kontorovich; R Gershoni-Baruch; E Dagan; H Jernström; M S Askmalm; B Arver; B Malmer; S M Domchek; K L Nathanson; J Brunet; T Ramón Y Cajal; D Yannoukakos; U Hamann; F B L Hogervorst; S Verhoef; E B Gómez García; J T Wijnen; A van den Ouweland; D F Easton; S Peock; M Cook; C T Oliver; D Frost; C Luccarini; D G Evans; F Lalloo; R Eeles; G Pichert; J Cook; S Hodgson; P J Morrison; F Douglas; A K Godwin; O M Sinilnikova; L Barjhoux; D Stoppa-Lyonnet; V Moncoutier; S Giraud; C Cassini; L Olivier-Faivre; F Révillion; J-P Peyrat; D Muller; J-P Fricker; H T Lynch; E M John; S Buys; M Daly; J L Hopper; M B Terry; A Miron; Y Yassin; D Goldgar; C F Singer; D Gschwantler-Kaulich; G Pfeiler; A-C Spiess; Thomas V O Hansen; O T Johannsson; T Kirchhoff; K Offit; K Kosarin; M Piedmonte; G C Rodriguez; K Wakeley; J F Boggess; J Basil; P E Schwartz; S V Blank; A E Toland; M Montagna; C Casella; E N Imyanitov; A Allavena; R K Schmutzler; B Versmold; C Engel; A Meindl; N Ditsch; N Arnold; D Niederacher; H Deissler; B Fiebig; R Varon-Mateeva; D Schaefer; U G Froster; T Caldes; M de la Hoya; L McGuffog; A C Antoniou; H Nevanlinna; P Radice; J Benítez
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.